|
In this symposium progress and applications of pharmacogenomics in oncology, neurodegenerative disease, psychiatry, hemato-oncology, cardio-vascular drugs and diabetes will be addressed. Also regulatory aspects, the use decision support tools and the application cell free DNA analysis as innovative biomarker to guide lung and/or prostate cancer therapy will be highlighted. During the meeting, there will be discussion groups, workshops and poster presentations as well as the ESPT General assembly.
Filippo DRAGO (University of Catania, Italy)
and Ron VAN SCHAIK (ESPT President, The Netherlands).
|
